Company / Working Capital
Voyager Therapeutics, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$176.1M
FY2025
5-year range
$51.9M / $255.2M
FY2021-FY2025
Trend
-22.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $52M in FY2022 to $255M in FY2023.
Based on SEC 10-K filings.
$176M in FY2025 with a 5-year CAGR of +0.6%.
Declined from $255M to $176M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +50.3%
- 5-Year CAGR
- +0.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.6%, indicating consistent growth.
- In FY2025, working capital decreased 22.4% year-over-year.
- Peak working capital was recorded in FY2023.
- Lowest working capital in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $176.1M | -22.4% |
| FY2024 | $227.0M | -11.0% |
| FY2023 | $255.2M | +391.6% |
| FY2022 | $51.9M | -39.4% |
| FY2021 | $85.7M | -49.9% |
| FY2020 | $171.0M | -25.2% |
| FY2019 | $228.6M | +74.8% |
| FY2018 | $130.8M | -16.1% |
| FY2017 | $155.9M | -5.5% |
| FY2016 | $165.0M | -4.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026